Australian Human Pluripotent Stem Cell Registry

HPIi003-A

Extracted from hPSCreg

iPS-7247-C5

Details

Tissue & Disease as reported

Biopsy Location

Ontology ID: fma9670

Label: Portion of blood

Definition: Portion of body substance which has as its parts plasma and blood cells.

Tissue for derived iPSC

Disease as reported (External Source)

Nemaline Myopathy 3

Genetic Information

Genotype Locus

ACTA1

Polymorphism

Heterozygous: NM_001100:c.515C>A(p.Ala172Glu)

Associated Publications

Journal	Year	Article
Stem cell research	2022	Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p.Ala172Glu) variant in the ACTA1 gene
Stem Cell Research	2022	Generation of an induced pluripotent stem cell line from a 3-month-old nemaline myopathy patient with a heterozygous dominant c.515C > A (p.Ala172Glu) variant in the ACTA1 gene.

Line Custodianship

Cell Line Maintainer

Clayton-HPI

View all cell lines from this group

Cell Line Producer

Harry Perkins Institute of Medical Research

Affiliated Institutions

Harry Perkins Institute of Medical Research, Nedlands, Australia

Source

External Cell Line

Genethon

Disease: {{ cell_source.external_cell_line_source.disease_phenotype.name }}

Derivation Details

Induced Pluripotent Cell Derivation Details

Source Cell Type: EFO:0022546
Label: LCL
Definition: Human cell line from tissue infected with Epstein-Barr virus, resembling a lymphoblast

Source Cell Origin: UBERON:0000178
Label: blood
Definition: A fluid that is composed of blood plasma and erythrocytes.

Derivation Year: 2021

Reprogramming Method

Vector Type:

Vector: Sendai Virus

Kit: [kit] CytoTune-iPS 2.0 Sendai reprogramming kit

Detected: {{ details.non_integrated_vector.get_detected_reprogramming_vector_display }}

Ethics

Ethics Number: RA/4/20/1008

Institution Human Research Ethics Council: University of Western Australia Human Research Ethics Committee

Approval Date: To be verified

Modifications

Genomic Modifications

Genotype: ACTA1

Polymorphism: Heterozygous: NM_001100:c.515C>A(p.Ala172Glu)

Quality Assurance

Genomic Characterisation

Passage Number: Not available

Karyotype: 46,XX

Karyotype Method: G-banding

Summary: Karyotyping occurred at a resolution of 400 to 500 bphs (15 metaphase spreads were counted; 7 were analysed in-depth).

STR analysis Results:

Performed but not available.

Microbiology and Virology Screening

Disease	Result
Mycoplasma	Negative

Characterisation of Undifferentiated Cells

Marker	Method
OCT4	Immunostaining
SOX2	Immunostaining
SSEA-4	Immunostaining
TRA-1-60	Immunostaining
CRIPTO	RT-qPCR
NANOG	RT-qPCR
OCT4	RT-qPCR
SOX2	RT-qPCR

Scorecard Results

Undifferentiated Cells

No available data for this cell line.